跳至主要内容
临床试验/ACTRN12607000245493
ACTRN12607000245493终止3 期

In children with mild obstructive sleep apnoea, is montelukast more effective than placebo in reducing the mixed and obstructive apnoea/hypopnoea index

School of Women's and Children's Health, University of New South Wales0 个研究点目标入组 40 人开始时间: 2007年5月8日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
2 Years 至 10 Years(—)
性别
All

入选标准

  • History of habitual snoring >= 4 nights per week for at least 6 months, Mixed Obstructive Apnoea-Hypopnoea Index (MOAHI) >1 and = 5 events per hour, Parents give written informed consent.

排除标准

  • MOAHI outside the inclusion range, Craniofacial, Neuromuscular, syndromic, developmental or genetic abnormalities, Current or past use of montelukast, Current upper respiratory tract infection, Use of any inhaled or systemic corticosteroids or antibiotics in the past 4 weeks, Previous surgical treatment for OSA or adenotonsillectomy.

研究者

发起方
School of Women's and Children's Health, University of New South Wales

相似试验

Montelukast for mild OSA in childre | 临床试验